Alric L - Search Results

1

"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.

Bureau C, Péron JM, Alric L, Morales J, Sanchez J, Barange K, Payen JL, Vinel JP. Bureau C, et al. Among authors: alric l. Hepatology. 2002 Dec;36(6):1361-6. doi: 10.1053/jhep.2002.36945. Hepatology. 2002. PMID: 12447860 Clinical Trial.

2

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.

Boulestin A, Sandres-Sauné K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J. Boulestin A, et al. Among authors: alric l. J Med Virol. 2002 Oct;68(2):221-8. doi: 10.1002/jmv.10192. J Med Virol. 2002. PMID: 12210411 Clinical Trial.

3

Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.

Alric L, Di-Martino V, Selves J, Cacoub P, Charlotte F, Reynaud D, Piette JC, Péron JM, Vinel JP, Durand D, Izopet J, Poynard T, Duffaut M, Rostaing L. Alric L, et al. Gastroenterology. 2002 Nov;123(5):1494-9. doi: 10.1053/gast.2002.36610. Gastroenterology. 2002. PMID: 12404224

4

Immunologically silent autochthonous acute hepatitis E virus infection in France.

Mansuy JM, Peron JM, Bureau C, Alric L, Vinel JP, Izopet J. Mansuy JM, et al. Among authors: alric l. J Clin Microbiol. 2004 Feb;42(2):912-3. doi: 10.1128/JCM.42.2.912-913.2004. J Clin Microbiol. 2004. PMID: 14766888 Free PMC article.

5

Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.

Alric L, Plaisier E, Thébault S, Péron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P. Alric L, et al. Am J Kidney Dis. 2004 Apr;43(4):617-23. doi: 10.1053/j.ajkd.2003.11.020. Am J Kidney Dis. 2004. PMID: 15042538 Clinical Trial.

6

Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.

Boulestin A, Kamar N, Legrand-Abravanel F, Sandres-Saune K, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. Among authors: alric l. Antimicrob Agents Chemother. 2004 Sep;48(9):3610-2. doi: 10.1128/AAC.48.9.3610-3612.2004. Antimicrob Agents Chemother. 2004. PMID: 15328140 Free PMC article.

7

Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.

Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J. Nicot F, et al. Among authors: alric l. J Gen Virol. 2005 Jan;86(Pt 1):107-114. doi: 10.1099/vir.0.80409-0. J Gen Virol. 2005. PMID: 15604436

8

Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.

Boulestin A, Sandres-Saune K, Alric L, Pipy B, Dubois M, Vinel JP, Izopet J. Boulestin A, et al. Among authors: alric l. Antivir Ther. 2005;10(4):499-504. Antivir Ther. 2005. PMID: 16038475

9

Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study.

Péron JM, Bureau C, Gonzalez L, Garcia-Ricard F, de Soyres O, Dupuis E, Alric L, Pourrat J, Vinel JP. Péron JM, et al. Among authors: alric l. Am J Gastroenterol. 2005 Dec;100(12):2702-7. doi: 10.1111/j.1572-0241.2005.00271.x. Am J Gastroenterol. 2005. PMID: 16393223

10

Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.

Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. Among authors: alric l. J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548. J Med Virol. 2006. PMID: 16419107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters